Home
RVTY
RVTY News

Latest Revvity Inc. (RVTY) News on April 28, 2025

Why Revvity (RVTY) Could Beat Earnings Estimates Again

Zacks

3 days ago

Why Revvity (RVTY) Could Beat Earnings Estimates Again

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Zacks

3 days ago

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Revvity Board Declares Quarterly Dividend

Business Wire

4 days ago

Revvity Board Declares Quarterly Dividend

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

Zacks

5 days ago

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

3 Cash-Producing Stocks Skating on Thin Ice

StockStory

5 days ago

3 Cash-Producing Stocks Skating on Thin Ice

Argus Research

6 days ago

RVTY: Lowering target price to $97.00

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

Zacks

7 days ago

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

MT Newswires

11 days ago

Leerink Partners Adjusts Price Target on Revvity to $135 From $140, Keeps Outperform Rating

MT Newswires

11 days ago

Wells Fargo Adjusts Price Target on Revvity to $102 From $130, Keeps Equalweight Rating

MT Newswires

12 days ago

Bernstein Adjusts Price Target on Revvity to $120 From $140, Maintains Market Perform Rating

Argus Research

13 days ago

RVTY: Raising target price to $100.00

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

Simply Wall St.

13 days ago

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

MT Newswires

14 days ago

BofA Securities Cuts Price Target on Revvity to $116 From $143, Maintains Buy Rating

MT Newswires

17 days ago

KeyBanc Lowers Price Target on Revvity to $135 From $145

Morningstar Research

18 days ago

Analyst Report: Revvity, Inc.

MT Newswires

18 days ago

Barclays Adjusts Price Target on Revvity to $110 From $140

MT Newswires

19 days ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Keeps Overweight Rating

Argus Research

20 days ago

RVTY: Lowering target price to $96.00

Revvity to Hold Earnings Call on Monday, April 28, 2025

Business Wire

25 days ago

Revvity to Hold Earnings Call on Monday, April 28, 2025

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

Medical Device Network

25 days ago

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

MT Newswires

a month ago

Evercore ISI Adjusts Revvity Price Target to $125 From $138, Maintains Outperform Rating

MT Newswires

a month ago

Revvity Says FDA Approves Auto-Pure 2400 Liquid Handler for Tuberculosis Test

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Business Wire

a month ago

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks

a month ago

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Argus Research

a month ago

RVTY: Lowering target price to $110.00

1 Healthcare Stock to Target This Week and 2 to Turn Down

StockStory

a month ago

1 Healthcare Stock to Target This Week and 2 to Turn Down

Argus Research

a month ago

RVTY: Lowering target price to $113.00

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years

Simply Wall St.

a month ago

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Zacks

a month ago

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Morningstar Research

a month ago

Analyst Report: Revvity, Inc.

MT Newswires

a month ago

Revvity Expands Alliance with Genomics England

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

Business Wire

a month ago

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

MT Newswires

a month ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively

Simply Wall St.

2 months ago

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively

Argus Research

2 months ago

RVTY: Lowering target price to $87.00

MT Newswires

2 months ago

Revvity Says Euroimmun Gets CE Mark for Measles Antibody Detection

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Business Wire

2 months ago

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

StockStory

2 months ago

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

Revvity Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.

2 months ago

Revvity Full Year 2024 Earnings: In Line With Expectations

3 Reasons to Sell RVTY and 1 Stock to Buy Instead

StockStory

2 months ago

3 Reasons to Sell RVTY and 1 Stock to Buy Instead

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?

Zacks

2 months ago

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?

Argus Research

2 months ago

RVTY: Raising target price to $92.00

MT Newswires

2 months ago

Revvity Wins Permanent Injunction Against Cloud Software Group

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Business Wire

2 months ago

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Revvity to Present at Upcoming Investor Conferences

Business Wire

2 months ago

Revvity to Present at Upcoming Investor Conferences

Argus Research

2 months ago

RVTY: Rating decreased to a SELL

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years”

Insider Monkey

2 months ago

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years”

Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Simply Wall St.

3 months ago

Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Argus Research

3 months ago

RVTY: Lowering target price to $129.00

MT Newswires

3 months ago

Raymond James Adjusts Price Target on Revvity to $145 From $140

MT Newswires

3 months ago

KeyBanc Adjusts Revvity Price Target to $145 From $132

MT Newswires

3 months ago

Bernstein Adjusts Revvity Price Target to $140 From $130, Maintains Market Perform Rating

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

GuruFocus.com

3 months ago

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Revvity Inc Earnings Call

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

StockStory

3 months ago

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

Morningstar Research

3 months ago

Analyst Report: Revvity, Inc.

MT Newswires

3 months ago

Citigroup Raises Price Target on Revvity to $155 From $145

RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust

Zacks

3 months ago

RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust

MT Newswires

3 months ago

Evercore ISI Adjusts Price Target on Revvity to $138 From $125

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

3 months ago

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say

Revvity (RVTY) Surpasses Q4 Earnings Estimates

Zacks

3 months ago

Revvity (RVTY) Surpasses Q4 Earnings Estimates

MT Newswires

3 months ago

Revvity Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Up Pre-Bell

Associated Press Finance

3 months ago

Revvity: Q4 Earnings Snapshot

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Business Wire

3 months ago

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

3 months ago

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Revvity Gears Up for Q4 Earnings: What's in the Offing?

Zacks

3 months ago

Revvity Gears Up for Q4 Earnings: What's in the Offing?

Argus Research

3 months ago

RVTY: Raising target price to $132.00

MT Newswires

3 months ago

Baird Adjusts Revvity Price Target to $137 From $138, Maintains Outperform Rating

Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barron’s Roundtable

Barrons.com

3 months ago

Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barron’s Roundtable

Revvity (RVTY) Earnings Expected to Grow: Should You Buy?

Zacks

3 months ago

Revvity (RVTY) Earnings Expected to Grow: Should You Buy?

Revvity Board Declares Quarterly Dividend

Business Wire

3 months ago

Revvity Board Declares Quarterly Dividend

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Zacks

3 months ago

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Argus Research

3 months ago

RVTY: Raising target price to $130.00

MT Newswires

3 months ago

Raymond James Adjusts Revvity Price Target to $140 From $146

Argus Research

3 months ago

RVTY: Raising target price to $127.00

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Zacks

3 months ago

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Business Wire

3 months ago

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Business Wire

4 months ago

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Revvity wins FDA clearance for ChLIA assay in free testosterone measurement

Medical Device Network

4 months ago

Revvity wins FDA clearance for ChLIA assay in free testosterone measurement

MT Newswires

4 months ago

Revvity Secures FDA Clearance for Automated Free Testosterone Test

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

Business Wire

4 months ago

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

MT Newswires

4 months ago

Bernstein Downgrades Revvity to Market Perform From Outperform, Adjusts Price Target to $130 From $145

No time to waste: Revvity CFO Max Krakowiak

CFO.com

4 months ago

No time to waste: Revvity CFO Max Krakowiak

MT Newswires

4 months ago

Evercore ISI Adjusts Price Target on Revvity to $125 From $134

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks

4 months ago

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Argus Research

4 months ago

RVTY: Lowering target price to $118.00

Argus Research

4 months ago

RVTY: Lowering target price to $120.00

Revvity to Present at J.P. Morgan Healthcare Conference

Business Wire

4 months ago

Revvity to Present at J.P. Morgan Healthcare Conference

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst

Benzinga

4 months ago

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst

MT Newswires

5 months ago

BofA Securities Upgrades Revvity to Buy From Neutral

Argus Research

5 months ago

RVTY: Raising target price to $124.00

Can Revvity, Inc. (NYSE:RVTY) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Simply Wall St.

5 months ago

Can Revvity, Inc. (NYSE:RVTY) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report?

Zacks

5 months ago

Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report?

Argus Research

5 months ago

RVTY: What does Argus have to say about RVTY?

Argus Research

5 months ago

RVTY: Raising target price to $121.00

Revvity price target lowered to $135 from $140 at Barclays

TipRanks

5 months ago

Revvity price target lowered to $135 from $140 at Barclays

MT Newswires

5 months ago

Barclays Adjusts Price Target on Revvity to $135 From $140, Keeps Overweight Rating

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Business Wire

5 months ago

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Business Wire

5 months ago

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Business Wire

5 months ago

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Share on Social Networks: